LDLR and hyperlipidemia: The risk of hyperlipidemia and AMI was markedly increased by approximately 4-fold in subjects with the LDLR rs769446356 or LDLR rs730882109 polymorphisms, and the risk of CAD increased significantly by 2-fold in those with the LDLR rs749038326 polymorphism.